The transatlantic healthcare landscape presents a complex tapestry of diverse models to cancer care. While both the United States and Europe boast remarkable advancements in oncology, significant discrepancies exist in their respective structures. This article delves into these distinctions, exploring the factors shaping them and highlighting poten